Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy

Wagner, Nikolaus B.; Lenders, Max M.; Kuehl, Kathrin; Reinhardt, Lydia; Fuchss, Milena; Ring, Natalie; Staeger, Ramon; Zellweger, Caroline; Ebel, Chiara; Kimeswenger, Susanne; Oellinger, Angela; Amaral, Teresa; Forschner, Andrea; Leiter, Ulrike; Klumpp, Bernhard; Hoetzenecker, Wolfram; Terheyden, Patrick; Mangana, Joanna; Loquai, Carmen; Cozzio, Antonio; Garbe, Claus; Meier, Friedegund; Eigentler, Thomas K.; Flatz, Lukas

Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy

Autor(en):

Wagner, Nikolaus B.; Lenders, Max M.; Kuehl, Kathrin; Reinhardt, Lydia; Fuchss, Milena; Ring, Natalie; Staeger, Ramon; Zellweger, Caroline; Ebel, Chiara; Kimeswenger, Susanne; Oellinger, Angela; Amaral, Teresa; Forschner, Andrea; Leiter, Ulrike; Klumpp, Bernhard; Hoetzenecker, Wolfram; Terheyden, Patrick; Mangana, Joanna; Loquai, Carmen; Cozzio, Antonio; Garbe, Claus; Meier, Friedegund; Eigentler, Thomas K.; Flatz, Lukas

Tübinger Autor(en):